These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Correlation between decrease of 11beta-hydroxysteroid dehydrogenase activity and hypokalemia induced by furosemide in rats. Yao B; Zhang YD; Shen JP Acta Pharmacol Sin; 2001 Nov; 22(11):991-6. PubMed ID: 11749789 [TBL] [Abstract][Full Text] [Related]
24. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172 [TBL] [Abstract][Full Text] [Related]
25. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188 [TBL] [Abstract][Full Text] [Related]
26. [Side effects and complication possibilities following high-dosage furosemide treatment]. Burmeister H; Ohlmeier H; Baethke R Med Klin; 1972 Oct; 67(43):1401-6. PubMed ID: 4264579 [No Abstract] [Full Text] [Related]
27. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion. Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481 [TBL] [Abstract][Full Text] [Related]
28. Furosemide-induced adverse reactions in cirrhosis of the liver. Naranjo CA; Pontigo E; Valdenegro C; González G; Ruiz I; Busto U Clin Pharmacol Ther; 1979 Feb; 25(2):154-60. PubMed ID: 759067 [TBL] [Abstract][Full Text] [Related]
29. Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Montoliu J; Lens XM; Revert L Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459 [TBL] [Abstract][Full Text] [Related]
30. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399 [TBL] [Abstract][Full Text] [Related]
31. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506 [TBL] [Abstract][Full Text] [Related]
32. Serum potassium monitoring for users of ethinyl estradiol/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes. Mona Eng P; Seeger JD; Loughlin J; Oh K; Walker AM Contraception; 2007 Feb; 75(2):101-7. PubMed ID: 17241838 [TBL] [Abstract][Full Text] [Related]
33. High-dose furosemide in the treatment of refractory congestive heart failure. Gerlag PG; van Meijel JJ Arch Intern Med; 1988 Feb; 148(2):286-91. PubMed ID: 3341836 [TBL] [Abstract][Full Text] [Related]
34. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Tamirisa KP; Aaronson KD; Koelling TM Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880 [TBL] [Abstract][Full Text] [Related]
35. Diuretic-induced hypokalemia. Schwartz AB Am Fam Physician; 1975 Jan; 11(1):101-4. PubMed ID: 1109534 [TBL] [Abstract][Full Text] [Related]
36. [Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension]. Bachour G Med Klin Prax; 1982 May; 77(10):54-8. PubMed ID: 6808328 [TBL] [Abstract][Full Text] [Related]
37. Drug-drug interactions with systemic antifungals in clinical practice. Depont F; Vargas F; Dutronc H; Giauque E; Ragnaud JM; Galpérine T; Abouelfath A; Valentino R; Dupon M; Hébert G; Moore N Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1227-33. PubMed ID: 17879355 [TBL] [Abstract][Full Text] [Related]
38. Long-acting and short-acting diuretics in the treatment of hypertension. Pupita F; Belogi M; Ansuini R; Campolucci G Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805 [TBL] [Abstract][Full Text] [Related]
39. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
40. Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. Ko DT; Juurlink DN; Mamdani MM; You JJ; Wang JT; Donovan LR; Tu JV J Card Fail; 2006 Apr; 12(3):205-10. PubMed ID: 16624686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]